Contact the Editorial Desk

Editorial correspondence

Physician-Only Peptides welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, a peer-reviewed study on Thymosin Alpha-1 or Thymulin that should be added to the references page, or a compound-identity conflation we have not flagged clearly enough. Corrections that improve the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible.

Editorial mailbox: editors@physcianonlypeptides.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things fall outside what this site can address. Physician-Only Peptides is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a particular research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Confirm or deny whether either peptide is safe or appropriate for any specific health context.
• Answer requests about whether either peptide is permitted in competitive sport — consult the relevant anti-doping authority and your own physician.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.